Authors: KAVLICK MF WYVILL K YARCHOAN R MITSUYA H

Citation: Mf. Kavlick et al., EMERGENCE OF MULTI-DIDEOXYNUCLEOSIDE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS, VIRAL SEQUENCE VARIATION, AND DISEASE PROGRESSION IN PATIENTS RECEIVING ANTIRETROVIRAL CHEMOTHERAPY, The Journal of infectious diseases, 177(6), 1998, pp. 1506-1513

Authors: YUSA K KAVLICK MF KOSALARAKSA P MITSUYA H

Citation: K. Yusa et al., HIV-1 ACQUIRES RESISTANCE TO 2 CLASSES OF ANTIVIRAL DRUGS THROUGH HOMOLOGOUS RECOMBINATION, Antiviral research, 36(3), 1997, pp. 179-189

Authors: TANAKA M SRINIVAS RV UENO T KAVLICK MF HUI FK FRIDLAND A DRISCOLL JS MITSUYA H

Citation: M. Tanaka et al., IN-VITRO INDUCTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS RESISTANT TO 2'-BETA-FLUORO-2',3'-DIDEOXYADENOSINE, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1313-1318

Authors: KAVLICK MF SHIRASAKA T KOJIMA E PLUDA JM HUI F YARCHOAN R MITSUYA H

Citation: Mf. Kavlick et al., GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF HIV-1 ISOLATED FROM PATIENTS RECEIVING (-)-2',3'-DIDEOXY-3'-THIACYTIDINE, Antiviral research, 28(2), 1995, pp. 133-146

Authors: SHIRASAKA T KAVLICK MF UENO T GAO WY KOJIMA E ALCAIDE ML CHOKEKIJCHAI S ROY BM ARNOLD E YARCHOAN R MITSUYA H

Citation: T. Shirasaka et al., EMERGENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH RESISTANCE TO MULTIPLE DIDEOXYNUCLEOSIDES IN PATIENTS RECEIVING THERAPY WITHDIDEOXYNUCLEOSIDES, Proceedings of the National Academy of Sciences of the United Statesof America, 92(6), 1995, pp. 2398-2402

Authors: KAVLICK MF KOJIMA E SHIRASAKA T PLUDA J YARCHOAN R MITSUYA H

Citation: Mf. Kavlick et al., DEVELOPMENT OF 3TC-RESISTANT HIV-1 IN PATIENTS RECEIVING 3TC, Clinical research, 42(2), 1994, pp. 10000280-10000280